We are live on ! Find out more
FM

Frazier Management Portfolio holdings

AUM $1.12M
1-Year Est. Return 151.58%
This Fund
S&P 500
This Quarter Est. Return
+5.01%
1 Year Est. Return
+151.58%
3 Year Est. Return
+408.4%
5 Year Est. Return
+1,802.6%
10 Year Est. Return
–
AUM
$1.11B
AUM Growth
-$24.9M
Cap. Flow
+$22M
Cap. Flow %
1.98%
Top 10 Hldgs %
85.85%
Holding
31
New
5
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
FRLN
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
+$9.19M
2
RGNX icon
Regenxbio
RGNX
+$5.68M
3
BLU
BELLUS Health Inc.
BLU
+$3.68M
4
NERV icon
Minerva Neurosciences
NERV
+$1.86M
5
CRDF icon
Cardiff Oncology
CRDF
+$1.72M

Top Sells

Rank Stock Value
1
ETTX
Entasis Therapeutics Holdings Inc.
ETTX
+$428K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRRA
26
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$2.16M 0.19%
202,803
– –
VTVT icon
27
vTv Therapeutics
VTVT
$130M
$1.88M 0.17%
26,550
– –
NERV icon
28
Minerva Neurosciences
NERV
$245M
$1.75M 0.16%
+68,750
New +$1.86M
ITRM
29
DELISTED
Iterum Therapeutics
ITRM
$1.61M 0.15%
102,554
– –
BLCM
30
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$691K 0.06%
105,144
– –
ETTX
31
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$408K 0.04%
199,953
-150,000
-43% -$428K
1
2

Similar funds

ACMV
August Capital Management VI Palo Alto, California $1.39M AUM
FRCMI
First Round Capital Management III Philadelphia, Pennsylvania $418K AUM
DB
DCVC Bio Palo Alto, California $313K AUM
NAM
Newfleet Asset Management Hartford, Connecticut $2.05M AUM 27.28% 1-Year Est. Return
AP
Atlas Principals Charlotte, North Carolina $2.19M AUM 56.71% 1-Year Est. Return
ID
Inspire Developers Forest Hills, New York $4.07M AUM
CI
CMT Investments Chicago, Illinois $5M AUM 15.27% 1-Year Est. Return
DIF
Discovery Investment Fund Singapore $6.98M AUM

Frazier Management's Q3 2020 Portfolio in Review

As of Q3 2020, Frazier Management held 31 positions worth $1.11B, down 2.2% from $1.14B the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Frazier Management's Q3 2020 filing shows 5 new, 1 increased and 1 reduced positions. Its largest new stake was Freeline Therapeutics Holdings plc American Depositary Shares: 36,667 shares worth $8.59M. The largest sale was Entasis Therapeutics Holdings Inc., an estimated $428K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Frazier Management's largest Q3 2020 buy was Freeline Therapeutics Holdings plc American Depositary Shares: 36,667 shares worth $8.59M.
  • Frazier Management added most to Trillium Therapeutics Inc. in Q3 2020, an estimated $333K increase.
  • Frazier Management's biggest Q3 2020 reduction was Entasis Therapeutics Holdings Inc., cutting an estimated $428K.
  • Frazier Management's ten largest holdings make up 86% of its $1.11B portfolio in Q3 2020.
  • Frazier Management opened 5 new positions and closed 0 in Q3 2020.
  • Frazier Management's portfolio value fell 2.2% quarter-over-quarter to $1.11B.

Based on Frazier Management's 13F filing for Q3 2020, filed 12 Nov 2020.